Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 148411-57-8
2. 77224-08-9
3. (2r,3s,4r,5r,6s)-5-amino-6-[(2r,3s,4r,5r,6r)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-2-(hydroxymethyl)oxane-3,4-diol
4. 2-amino-4-o-(2-amino-2-deoxy-beta-d-glucopyranosyl)-2-deoxy-beta-d-glucopyranose
5. B-d-glucopyranose,2-amino-4-o-(2-amino-2-deoxy-b-d-glucopyranosyl)-2-deoxy-
6. (2r,3r,4r,5s,6r)-3-amino-5-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-2,4-diol
7. Deacetylated Chitin
8. Poly(d-glucosamine)
9. Schembl186177
10. Chebi:50677
11. Dtxsid80584131
12. Zinc25723126
13. Akos037515792
14. Cs-0239055
15. Chitosan Oligosaccharide Lactate, Average Mn 5,000
16. Q27122179
17. 4-o-(2-amino-2-deoxy-beta-d-glucopyranosyl)-beta-d-glucosamine
18. Wurcs=2.0/1,2,1/[a2122h-1b_1-5_2*n]/1-1/a4-b1
19. 2-amino-4-o-(2-amino-2-deoxy-
20. A-d-glucopyranosyl)-2-deoxy-
21. A-d-glucopyranose
Molecular Weight | 340.33 g/mol |
---|---|
Molecular Formula | C12H24N2O9 |
XLogP3 | -5.2 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 4 |
Exact Mass | 340.14818035 g/mol |
Monoisotopic Mass | 340.14818035 g/mol |
Topological Polar Surface Area | 201 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 390 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Chitosan Oligosaccharide Lactate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chitosan Oligosaccharide Lactate, including repackagers and relabelers. The FDA regulates Chitosan Oligosaccharide Lactate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chitosan Oligosaccharide Lactate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chitosan Oligosaccharide Lactate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chitosan Oligosaccharide Lactate supplier is an individual or a company that provides Chitosan Oligosaccharide Lactate active pharmaceutical ingredient (API) or Chitosan Oligosaccharide Lactate finished formulations upon request. The Chitosan Oligosaccharide Lactate suppliers may include Chitosan Oligosaccharide Lactate API manufacturers, exporters, distributors and traders.
click here to find a list of Chitosan Oligosaccharide Lactate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chitosan Oligosaccharide Lactate DMF (Drug Master File) is a document detailing the whole manufacturing process of Chitosan Oligosaccharide Lactate active pharmaceutical ingredient (API) in detail. Different forms of Chitosan Oligosaccharide Lactate DMFs exist exist since differing nations have different regulations, such as Chitosan Oligosaccharide Lactate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Chitosan Oligosaccharide Lactate DMF submitted to regulatory agencies in the US is known as a USDMF. Chitosan Oligosaccharide Lactate USDMF includes data on Chitosan Oligosaccharide Lactate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Chitosan Oligosaccharide Lactate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Chitosan Oligosaccharide Lactate suppliers with USDMF on PharmaCompass.
Chitosan Oligosaccharide Lactate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chitosan Oligosaccharide Lactate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chitosan Oligosaccharide Lactate GMP manufacturer or Chitosan Oligosaccharide Lactate GMP API supplier for your needs.
A Chitosan Oligosaccharide Lactate CoA (Certificate of Analysis) is a formal document that attests to Chitosan Oligosaccharide Lactate's compliance with Chitosan Oligosaccharide Lactate specifications and serves as a tool for batch-level quality control.
Chitosan Oligosaccharide Lactate CoA mostly includes findings from lab analyses of a specific batch. For each Chitosan Oligosaccharide Lactate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chitosan Oligosaccharide Lactate may be tested according to a variety of international standards, such as European Pharmacopoeia (Chitosan Oligosaccharide Lactate EP), Chitosan Oligosaccharide Lactate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chitosan Oligosaccharide Lactate USP).
LOOKING FOR A SUPPLIER?